Posted by Michael Wonder on 15 Feb 2022
NICE recommends new diagnostic devices for men with suspected prostate cancer in draft guidance
15 February 2022 - Four new diagnostic devices for men with suspected prostate cancer, which reduce the chances of biopsy related sepsis, have been recommended for use by NICE.
The new diagnostics guidance looks at local anaesthetic transperineal (LATP) prostate biopsy, using the freehand needle positioning devices PrecisionPoint, EZU-PA3U device, Trinity Perine Grid, and UA1232 puncture attachment, which are recommended as options for helping to diagnose prostate cancer.
